柳工(000528.SZ):公司吸收合併柳工有限申請事項中止審查
格隆匯8月22日丨柳工(000528.SZ)公佈,公司擬通過向廣西柳工集團機械有限公司(以下簡稱"柳工有限")的全體股東發行股份,吸收合併柳工有限。此次重組項目申請於2021年6月21日獲得中國證券監督管理委員會(以下簡稱"中國證監會")受理,並於2021年7月20日收到《中國證監會行政許可項目審查一次反饋意見通知書》(211506號)。
公司為此次重組聘請的律師事務所因其為其他公司提供的法律服務而被中國證監會立案調查,目前尚未最終結案。根據《中國證券監督管理委員會行政許可實施程序規定》第二十二條第一款第(三)項的有關規定,中國證監會決定中止對此次重組申請的審查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.